Use mefloquine for UK troops only as “last resort,” MPs tell Ministry of DefenceBMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i2946 (Published 24 May 2016) Cite this as: BMJ 2016;353:i2946
- Caroline White
British military personnel should be given the antimalarial drug mefloquine (which is marketed in the United Kingdom as Lariam) only as a “last resort,” MPs have concluded.1
In a report into the use of the drug among the armed forces, the House of Commons Defence Committee accused the Ministry of Defence of displaying a “lamentable weakness in [its] duty of care towards service personnel” and of ignoring the “stringent conditions” for safe prescribing set out by the drug’s manufacturer, Roche.
“We see no reason to disbelieve the very strong anecdotal evidence that such conditions have been ignored in dispensing it to large numbers of troops about to be deployed. Indeed, it is hard to see how they could ever be met except when the numbers …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial